Quiz

Key Barriers to Tardive Dyskinesia Diagnosis

11/18/2024

Tardive dyskinesia (TD) is a hyperkinetic movement disorder that is often irreversible. It is typically caused by exposure to antipsychotic medications used to treat mental illnesses such as major depressive disorder, bipolar disorder, and schizophrenia. (source)

Quiz Reference

Tumolo J. Patient survey identifies barriers to TD treatment. Psych Congress Network. November 6, 2024. Accessed November 18, 2024.

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Key Barriers to Tardive Dyskinesia Diagnosis

Tardive dyskinesia (TD) is a hyperkinetic movement disorder that is often irreversible. It is typically caused by exposure to antipsychotic medications used to treat mental illnesses such as major depressive disorder, bipolar disorder, and schizophrenia. (source)

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products